Karyopharm Therapeutics (KPTI) Capital Expenditures (2013 - 2024)
Karyopharm Therapeutics' Capital Expenditures was -$53,000 in Q4 2024.
Analysis
Karyopharm Therapeutics (KPTI) Capital Expenditures (2013 - 2024) Analysis & Trends
For FY2024, Capital Expenditures at Karyopharm Therapeutics came in at $142,000.
- Capital Expenditures shows a five-year compound annual growth rate of -7.2% (FY2019 to FY2024).
- In earlier years, Capital Expenditures was $118,000 in FY2022 (-44.3%), $212,000 in FY2021 (+46.2%) and $145,000 in FY2020 (-29.6%).
- The Q4 2024 figure marks the lowest quarterly Capital Expenditures in data going back to Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -53,000.00 |
| Mar 31, 2024 | 195,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | 207,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Dec 31, 2020 | 119,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 107,000.00 |
| Mar 31, 2019 | 49,000.00 |
| Dec 31, 2018 | 1.09 Mn |
| Sep 30, 2018 | 491,000.00 |
| Jun 30, 2018 | 397,000.00 |
| Mar 31, 2018 | 382,000.00 |
| Dec 31, 2017 | 55,000.00 |
| Dec 31, 2016 | 25,000.00 |
| Jun 30, 2016 | 6,000.00 |
| Mar 31, 2016 | 39,000.00 |
API Access
Karyopharm Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KPTI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();